| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.08B | +7.4% |
| R&D Expense | $20.4M | — |
| SG&A Expense | $132.7M | +1.5% |
| Operating Income | $112.3M | +14.2% |
| Pre-tax Income | $115.2M | +8.7% |
| Income Tax | $35.8M | +6.9% |
| Net Income | $79.5M | +9.5% |
| EPS (Basic) | $4.02 | +8.1% |
| EPS (Diluted) | $3.86 | +7.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $355.4M | -34.8% |
| Short-term Investments | $266.2M | — |
| Accounts Receivable | $126.4M | -5.5% |
| Current Assets | $823.8M | +10.5% |
| Total Assets | $1.18B | +6.2% |
| Current Liabilities | $588.5M | +10.1% |
| Total Liabilities | $765.0M | -0.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $119.3M | -56.0% |
| Capital Expenditures | $11.1M | +78.4% |
| Investing Cash Flow | -$279.6M | -1215.2% |
| Financing Cash Flow | -$15.7M | -1.1% |
| Free Cash Flow | $108.2M | -59.2% |
| Stockholders' Equity |
| $410.6M |
| +22.2% |